BridgeMD
New treatment option for Hiv
Official title Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)
ClinicalTrials.gov ID: NCT06541028
What this study is testing
- What it's testing
- This study seeks to develop an RS-ART implementation strategy by utilizing the Delphi method and interviewing experts and PWID regarding their experiences with ART. This strategy will then be pilot tested in a randomized controlled trial (Aim 3).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- PWID in general population:
- Be a PWID from the general population enrolling into ART services at one of the study's HIV clinics. PWID can include patients injecting opioids...
- Provide informed consent.
- HIV clinicians prescribing ART
- Be the HIV clinician who prescribes ART for a PWID in one of the selected clinics.
See the full eligibility criteria
- PWID in general population:
- Be a PWID from the general population enrolling into ART services at one of the study's HIV clinics. PWID can include patients injecting opioids, amphetamines, or other combinations of injectable drugs. Some of these...
- Provide informed consent.
- HIV clinicians prescribing ART
- Be the HIV clinician who prescribes ART for a PWID in one of the selected clinics.
- Be willing to use the RS-ART protocol.
- Be at least 18 years old. No minors below age 18 will be enrolled in the study.
- Provide informed consent. PWID in prison population:
- Be a PWID enrolling into ART services at Kajang prison. PWID can include patients injecting opioids, amphetamines, or other combinations of injectable drugs. Some of these patients may be diagnosed with Opioid Use...
- Provide informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Kajang, Malaysia
- Kuala Lumpur, Malaysia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kajang, Malaysia; Kuala Lumpur, Malaysia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.